Neuberger Berman Group LLC Axogen, Inc. Transaction History

Neuberger Berman Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$7.35 - $10.81 $1.94 Million - $2.86 Million	-264,372 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$8.38 - $17.34 $2.61 Million - $5.41 Million	-311,963 Reduced 54.13%	264,372 $2.75 Million
Q4 2019 Feb 12, 2020	SELL	$11.18 - $18.6 $23,478 - $39,060	-2,100 Reduced 0.36%	576,335 $10.3 Million
Q3 2019 Nov 13, 2019	BUY	$12.09 - $20.46 $6.99 Million - $11.8 Million	578,435 New	578,435 $7.22 Million
Q2 2019 Aug 13, 2019	SELL	$18.5 - $25.47 $4.88 Million - $6.72 Million	-264,000 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$14.62 - $22.13 $14,620 - $22,130	-1,000 Reduced 0.38%	264,000 $5.56 Million
Q4 2018 Feb 12, 2019	SELL	$17.09 - $38.25 $341,800 - $765,000	-20,000 Reduced 7.02%	265,000 $5.41 Million
Q3 2018 Nov 13, 2018	BUY	$34.05 - $55.9 $2.93 Million - $4.81 Million	86,000 Added 43.22%	285,000 $10.5 Million
Q2 2018 Aug 13, 2018	BUY	$36.15 - $52.5 $5.39 Million - $7.82 Million	149,000 Added 298.0%	199,000 $10 Million
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $407,000 - $629,200	22,000 Added 78.57%	50,000 $1.42 Million
Q3 2017 Nov 15, 2017	BUY	$14.65 - $19.35 $410,200 - $541,800	28,000	28,000 $542,000

129

35.8M

79.1K

500

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $593M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.